Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials von Yang, H., Mir, R., Díez, P., Tsang, Y., Conibear, J., Simões, R., Cox, S., Webster, A., Nabi, Z., Eaton, D., Naismith, O., Whilde, N., Miles, E.

Volltext

1490 poster AN EVALUATION OF IMSIMQA AS A TOOL FOR COMMISSIONING 4DCT von McGOWAN, S, Whilde, N

Volltext

126: Our experience in treating lung tumours using stereotactic ablative body radiotherapy (SABR) at Northampton General Hospital von Yusof, H, Gore, A, Mak, C.I, Eldeeb, H, Vaidya, D, Acquah, H, Whilde, N

Volltext

142: IMRT for treating lung cancer – our experience at Northampton General Hospital von Vaidya, D, Acquah, H, Guinee, L, York, C, Whilde, N, Blackmore, A, Duggleby, S, Yusof, H, Jackson, A.H, Patil, R, Mak, C.I, Gore, A

Volltext

1489 poster ACHIEVING GTV CONSISTENCY IN A DEPARTMENT – USE OF A CONTOUR COMPARISON TOOL von Whilde, N, Mukherjee, S, Andrade, G, Macmillan, C, Halle, C

Volltext

EP-1834: EPID calibration assessments and implications for transit dosimetry von Valera Lopez, J., Savva, S., Whilde, N., Duggleby, S.

Volltext

OC-0421: Consistency of organs at risk delineation guidance in UK radiotherapy clinical trials von Yang, H., Diez, P., Tsang, Y., Conibear, J., Cox, S., Gulliford, S., Naismith, O., Simões, R., Whilde, N., Miles, E., Eaton, D.

Volltext